Search Results - "Frick, Glen S."

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
  2. 2

    Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer by Frick, Glen S, Pitari, Giovanni M, Weinberg, David S, Hyslop, Terry, Schulz, Stephanie, Waldman, Scott A

    Published in Expert review of molecular diagnostics (01-09-2005)
    “…Staging patients with colorectal cancer defines their prognosis and therapeutic management. Unfortunately, histopathology, the current standard for staging, is…”
    Get more information
    Journal Article
  3. 3

    Effect of Aprepitant on the Pharmacokinetics of Intravenous Midazolam by Majumdar, Anup K., Yan, Kerri X., Selverian, Diana V., Barlas, Suna, Constanzer, Marvin, Dru, James, McCrea, Jacqueline B., Ahmed, Tuli, Frick, Glen S., Kraft, Walter K., Petty, Kevin J., Greenberg, Howard E.

    Published in Journal of clinical pharmacology (01-06-2007)
    “…Oral aprepitant 125 mg, an antiemetic and a moderate inhibitor of the metabolism of oral midazolam, was assessed for interaction with intravenous midazolam in…”
    Get full text
    Journal Article
  4. 4
  5. 5

    The effects of cocaine on cerebral metabolic function in periweanling rats: the roles of serotonergic and dopaminergic uptake blockade by Frick, Glen S., Dow-Edwards, Diana L.

    “…This report examines the short-term effects of cocaine exposure during postnatal (PoN) days 11–21 on the metabolic function of major central neuronal systems…”
    Get full text
    Journal Article